Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM‐induced autophagy or BAX
Authors:
Open Access
- 16 June 2013
- journal article
- metabolic and-steatohepatitis
- Published by Wiley in Liver International
- Vol. 33 (10) , 1566-1574
Abstract
Background & Aims: Apoptosis mediated by p53 plays a pathological role in the progression of hepatosteatosis. It is noteworthy that p53 can promote the expression of damage‐regulated autophagy modulator (DRAM), an inducer of autophagy‐mediated apoptosis. However, the relationship between p53‐mediated apoptosis and autophagy in hepatosteatosis remains elusive. This study aimed to examine how p53 orchestrates autophagy and apoptosis to affect hepatosteatosis.Methods: HepG2 cells were treated with oleic acid (OA) for 24 h to induce hepatosteatosis. Mice were fed a high‐fat diet for 20 or 40 weeks to induce hepatosteatosis.Results: OA induced a dose‐dependent increase in steatosis severity and apoptosis. OA also induced autophagy, which was a critical inducer of apoptosis in mild steatosis induced by 400 μM OA, but not in the more severe steatosis induced by 800 and 1200 μM OA. p53 inhibition by siRNA mostly blocked OA‐induced apoptosis and autophagy. Moreover, OA‐induced autophagy was DRAM‐dependent and primarily occurred in the mitochondria (mitophagy), where DRAM was localized. In severe steatosis induced by 1200 μM OA, apoptosis was mainly dependent on p53‐induced expression of BAX, which was also localized to the mitochondria. Our in vivo study showed that p53 expression increased in both mild and severe hepatosteatosis. Increased DRAM expression and autophagy were identified in mild hepatosteatosis, whereas greater BAX expression was observed in severe hepatosteatosis.Conclusions: p53 may induce apoptosis via different mechanisms. DRAM‐mediated mitophagy is a primary apoptotic inducer in mild hepatosteatosis, whereas p53‐induced BAX expression mainly induces apoptosis in severe hepatosteatosis.Keywords
This publication has 40 references indexed in Scilit:
- p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and miceJournal of Hepatology, 2012
- Endoplasmic Reticulum Stress in Nonalcoholic Fatty Liver DiseaseAnnual Review of Nutrition, 2012
- p53 Dynamics Control Cell FateScience, 2012
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical ImplicationsGastroenterology, 2012
- The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatmenOncology Reports, 2011
- Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.Acta Biochimica Polonica, 2011
- Differential Roles of Unsaturated and Saturated Fatty Acids on Autophagy and Apoptosis in HepatocytesThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Differentiation between Cell Death Modes Using Measurements of Different Soluble Forms of Extracellular Cytokeratin 18Cancer Research, 2004
- Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitisGastroenterology, 2003
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998